| Latest Biomira - Common Shares News Headlines |
| Date | Time | Source | |
| 12/05/2007 | 12:52PM | PRNUS | Court issues final order approving Biomira's move to U.S. and name change to Oncothyreon
EDMONTON, Dec. 5 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) ("Biomira", the "Company") announced that the Alberta Court of Queen's Bench today issued a Final Order approving the plan of arrangement under which the Company will move to the United States and change its name to Oncothyreon Inc. ("Oncothyreon... More...>> |
| 12/04/2007 | 11:57AM | PRNUS | Biomira Shareholders Approve Move to U.S.
EDMONTON, Dec. 4 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) ("Biomira", the "Company") today announced that the Company's shareholders have approved a plan of arrangement under which the Company will move to the United States and change its name to Oncothyreon Inc. ("Oncothyreon"). The approval... More...>> |
| 11/05/2007 | 8:16AM | PRNUS | Biomira Inc. receives Nasdaq delisting notification
EDMONTON, Nov. 5 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) (the "Company") today announced that on November 2, 2007, it received a letter from The Nasdaq Stock Market, Inc. ("Nasdaq") notifying the Company that for the 30 consecutive trading days preceding the date of the letter, the bid price... More...>> |
| 11/01/2007 | 8:02AM | PRNUS | Biomira Inc. announces date for special meeting of shareholders; Oncothyreon Inc. registration statement declared effective
EDMONTON, and BELLEVUE, WA, Nov. 1 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) (the "Company") today announced that it will hold a special meeting of shareholders at 9:00 a.m. Mountain Time on December 4, 2007, at the Delta Edmonton South Hotel & Conference Centre, 4404 Gateway Blvd., Edmonton. The... More...>> |
| 11/01/2007 | 8:00AM | PRNUS | Biomira announces third quarter 2007 financial results
EDMONTON, Nov. 1 /PRNewswire-FirstCall/ -- Biomira Inc. ("Biomira" or the "Company") (NASDAQ:BIOM) (TSX:BRA) today reported a consolidated net loss of $6.8 million or $0.06 per basic and diluted share for the three months ended September 30, 2007, compared to $3.7 million or $0.04 per basic and diluted share for the... More...>> |
| 10/30/2007 | 8:00AM | PRNUS | Biomira to present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
EDMONTON, Oct. 30 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference in New York at 11:15am ET/8:15am PT on Tuesday, November 6... More...>> |
| 10/24/2007 | 8:00AM | PRNUS | New data may help guide the clinical development of Biomira's PX-478 and PX-866
EDMONTON, Oct. 24 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) announced today that preclinical data for its targeted anti-cancer drug candidates PX-478 and PX-866 were presented in a poster session yesterday at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics... More...>> |
| 10/03/2007 | 10:30AM | PRNUS | Biomira to present at the BIO InvestorForum 2007
EDMONTON, Oct. 3 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the BIO InvestorForum 2007 in San Francisco at 2:45pm PDT/5:45pm EDT on Wednesday, October 10.
The presentation is planned for... More...>> |
| 09/27/2007 | 4:51PM | PRNUS | Biomira announces plan to change name to Oncothyreon
EDMONTON, Sept. 27 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) (the "Company") today announced that, as part of the Company's previously announced plan to reincorporate in the United States, it intends to change its name to Oncothyreon Inc. The name change will become effective upon shareholder and... More...>> |
| 09/12/2007 | 9:04AM | PRNUS | Biomira Announces Plan to Reincorporate in the United States
COMPANY TO HOST CONFERENCE CALL AT 10:00AM EDT
EDMONTON, BELLEVUE, WASHINGTON, Sept. 12 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) (the "Company") today announced that the Company's Board of Directors has approved a proposal to change its jurisdiction of incorporation from the federal jurisdiction... More...>> |
| 09/05/2007 | 8:00AM | PRNUS | Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
EDMONTON, Sept. 5 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced the presentation of three-year survival results from a randomized Phase II trial of the Stimuvax(R) MUC-1 vaccine in non-small cell lung cancer (NSCLC). The results suggest that Stimuvax combined with best supportive care... More...>> |
| 08/28/2007 | 8:00AM | PRNUS | Biomira initiates Phase 1 trial of PX-478 in patients with advanced metastatic cancers
EDMONTON, Aug. 28 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced that the first patient has been enrolled in a Phase 1 clinical trial of PX-478 in patients with advanced metastatic cancer. PX-478 is a novel small molecule compound designed to inhibit the activity of hypoxia inducible... More...>> |
| 08/08/2007 | 8:00AM | PRNUS | Biomira and Merck KGaA sign amended and restated collaboration and supply agreements related to Stimuvax(R)
EDMONTON, Aug. 8 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced the signing of amended and restated collaboration and supply agreements related to Stimuvax(R) with Merck KGaA of Darmstadt, Germany. The amended agreements restructure the agreements originally signed in 2001, and are based... More...>> |
| 08/02/2007 | 5:00AM | PRNUS | Biomira announces second quarter 2007 financial results
EDMONTON, Aug. 2 /PRNewswire-FirstCall/ -- Biomira Inc. ("Biomira" or the "Company") (NASDAQ:BIOM) (TSX:BRA) today reported a consolidated net loss from operations of $6.3 million or $0.05 per basic and diluted share for the three months ended June 30, 2006, compared to $4.0 million or $0.04 per basic and diluted share... More...>> |
| 07/17/2007 | 8:00AM | PRNUS | Biomira appoints industry veteran as Chief Operating Officer
EDMONTON, July 17 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced the appointment of Gary Christianson to the newly created position of Chief Operating Officer. Mr. Christianson brings to Biomira more than 20 years of operational expertise in diverse areas, including technical development... More...>> |
| 07/03/2007 | 8:00AM | PRNUS | Biomira files investigational new drug application for PX-478, a novel inhibitor of hypoxia-inducible factor-1 alpha
EDMONTON, July 3 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for PX-478. PX-478 has been shown in preclinical studies to inhibit hypoxia-inducible factor (HIF)-1 alpha, a protein... More...>> |
| 05/08/2007 | 8:00AM | PRNUS | Biomira to Present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference
EDMONTON, May 8 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference at 3:35pm CEST/9:35am EDT/6:35am PDT on Monday, May 14th... More...>> |
| 04/26/2007 | 4:00PM | PRNUS | Biomira Inc. announces first quarter 2007 results
EDMONTON, April 26 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX:BRA) today reported a consolidated net loss from operations of $5.4 million or $0.05 per basic and diluted share for the three months ended March 31, 2007, compared to $5.8 million or $0.07 per basic and diluted share for the same period in... More...>> |
| 04/16/2007 | 8:00AM | PRNUS | Biomira selects PX-866 as clinical development candidate and presents promising preclinical data at AACR
-IND filing expected by end of 2007-
EDMONTON, April 16 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced that it has selected PX-866 as its next clinical development candidate. PX-866 is an inhibitor of the phosphatidylinositol-3-kinase (PI3 kinase)/ PTEN/AKT pathway, an important survival... More...>> |
| 03/08/2007 | 4:00PM | PRNUS | Biomira reports Full year and Fourth Quarter 2006 Financial Results
EDMONTON, March 8 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today reported financial results for the year and quarter ended December 31, 2006. All results are in Canadian dollars.
Net loss for the year ended December 31, 2006, was $17.8 million or $0.19 per basic and diluted share, compared with... More...>> |